ARCHIVES

Interim Funding: Noncompeting Renewals Reduced By 4 Percent, Competing Current Plus 7 Percent

This article is from The Cancer Letter archive.

Vol. 08 No. 02 | January 8, 1982

Download PDF Visit The Full Archive

Related Articles

ASCO Supports Tobacco Tax Increase

March 7, 2003

In Brief: IOM Cancer Policy Forum names six at-large members

August 1, 2014

NIH Clinical Trials Committee Adopts Recommendations For Safety Monitoring

June 22, 1979

FDA Proposes “Clarification” Of Clinical Studies regulations, Including Sanctions, Inspections

August 18, 1978

Preliminary Study Results Show DES In Utero Exposure May Not Be Threat Originally Feared

February 17, 1978

MicroRNA Biomarkers Linked To Early-Stage Prostate Cancer

February 24, 2012